gimeracil
Term · Oncology and biomedicine · MLC-T-ONC-013940
A pyridine derivative with antitumor activity. Gimeracil enhances the antitumor activity of fluoropyrimidines by competitively and reversibly inhibiting the enzyme dihydropyrimidine dehydrogenase causing decreased degradation of the fluoropyrimidines.
| Identifier | MLC-T-ONC-013940 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | CDHP |
| Synonyms | chlorodihydroxypyridine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013940",
"term": "gimeracil",
"field": "Oncology and biomedicine",
"definition": "A pyridine derivative with antitumor activity. Gimeracil enhances the antitumor activity of fluoropyrimidines by competitively and reversibly inhibiting the enzyme dihydropyrimidine dehydrogenase causing decreased degradation of the fluoropyrimidines.",
"abbreviation": "CDHP",
"synonyms": [
"chlorodihydroxypyridine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/gimeracil/"
}
Record 7,977 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.